Enveric Biosciences, Inc. SEC filings ENVB
Enveric Biosciences, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 30, 2001. Its latest annual report, Form ARS, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jun 9, 2026 | — |
| S-8 | Employee stock plan registration | Jun 1, 2026 | — |
| 424B3 | Prospectus | Apr 29, 2026 | — |
| S-3 | Shelf registration | Apr 23, 2026 | — |
| 424B3 | Prospectus | Feb 18, 2026 | — |
| S-1 | Registration statement | Feb 10, 2026 | — |
| 424B5 | Prospectus supplement | Feb 6, 2026 | — |
| 424B5 | Prospectus supplement | Jan 28, 2026 | — |
| 424B3 | Prospectus | Dec 31, 2025 | — |
| S-3 | Shelf registration | Dec 22, 2025 | — |
| S-8 | Employee stock plan registration | Dec 22, 2025 | — |
| 424B3 | Prospectus | Dec 10, 2025 | — |
| S-3/A | Filing | Dec 5, 2025 | — |
| S-3 | Shelf registration | Sep 29, 2025 | — |
| S-3/A | Filing | Apr 10, 2025 | — |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| 424B4 | Prospectus | Feb 3, 2025 | — |
| S-1/A | Amended registration statement | Jan 30, 2025 | — |
| S-1/A | Amended registration statement | Jan 30, 2025 | — |
| S-1 | Registration statement | Jan 14, 2025 | — |
| 424B4 | Prospectus | Sep 12, 2024 | — |
| S-1 | Registration statement | Sep 4, 2024 | — |
| S-3 | Shelf registration | Jul 8, 2024 | — |
| 424B5 | Prospectus supplement | May 3, 2024 | — |
| 424B5 | Prospectus supplement | Mar 11, 2024 | — |
| 424B3 | Prospectus | Jan 24, 2024 | — |
| S-3 | Shelf registration | Jan 11, 2024 | — |
| 424B4 | Prospectus | Dec 6, 2023 | — |
| S-1/A | Amended registration statement | Dec 1, 2023 | — |
| S-1 | Registration statement | Nov 8, 2023 | — |
| 424B5 | Prospectus supplement | Sep 1, 2023 | — |
| S-8 | Employee stock plan registration | Jan 20, 2023 | — |
| 424B3 | Prospectus | Aug 12, 2022 | — |
| S-3 | Shelf registration | Aug 5, 2022 | — |
| 424B3 | Prospectus | Jul 28, 2022 | — |
| 424B5 | Prospectus supplement | Jul 26, 2022 | — |
| 424B5 | Prospectus supplement | Feb 15, 2022 | — |
| 424B5 | Prospectus supplement | Feb 11, 2022 | — |
| 424B5 | Prospectus supplement | Feb 10, 2022 | — |
| 424B3 | Prospectus | Aug 6, 2021 | — |
| S-4/A | Filing | Aug 4, 2021 | — |
| S-3 | Shelf registration | Jul 2, 2021 | — |
| S-4 | Registration for a merger or exchange | Jun 22, 2021 | — |
| 424B3 | Prospectus | Apr 8, 2021 | — |
| S-3/A | Filing | Apr 2, 2021 | — |
| S-3 | Shelf registration | Feb 16, 2021 | — |
| 424B5 | Prospectus supplement | Feb 11, 2021 | — |
| S-3MEF | Filing | Feb 9, 2021 | — |
| 424B5 | Prospectus supplement | Jan 13, 2021 | — |
| S-4MEF | Filing | Dec 28, 2020 | — |
| 424B3 | Prospectus | Nov 13, 2020 | — |
| S-4/A | Filing | Nov 10, 2020 | — |
| S-4/A | Filing | Nov 9, 2020 | — |
| S-4/A | Filing | Oct 22, 2020 | — |
| S-4/A | Filing | Sep 17, 2020 | — |
| S-4/A | Filing | Aug 12, 2020 | — |
| 424B5 | Prospectus supplement | Aug 4, 2020 | — |
| 424B5 | Prospectus supplement | Jun 4, 2020 | — |
| S-4 | Registration for a merger or exchange | May 28, 2020 | — |
| 424B5 | Prospectus supplement | Jan 13, 2020 | — |
| 424B5 | Prospectus supplement | Nov 26, 2019 | — |
| S-3/A | Form s-3/a | Nov 15, 2019 | — |
| S-3 | Shelf registration | Aug 14, 2019 | — |
| 424B3 | Prospectus | Nov 21, 2018 | — |
| S-1 | Registration statement | Nov 13, 2018 | — |
| 424B3 | Prospectus | Oct 24, 2018 | — |
| S-1/A | Amended registration statement | Oct 23, 2018 | — |
| S-1/A | Amended registration statement | Oct 22, 2018 | — |
| S-1/A | Amended registration statement | Sep 25, 2018 | — |
| S-8 | Employee stock plan registration | Sep 7, 2018 | — |
| S-1 | Registration statement | Aug 24, 2018 | — |
| 424B4 | Prospectus | Nov 20, 2017 | — |
| POS AM | Filing | Nov 15, 2017 | — |
| FWP | Free writing prospectus | Nov 14, 2017 | — |
| S-1/A | Amended registration statement | Nov 8, 2017 | — |
| S-1/A | Amended registration statement | Nov 6, 2017 | — |
| S-1/A | Amended registration statement | Oct 27, 2017 | — |
| S-1/A | Amended registration statement | Oct 25, 2017 | — |
| S-1 | Registration statement | Sep 18, 2017 | — |
| S-1/A | Amended registration statement | Jun 22, 2017 | — |
| S-1/A | Amended registration statement | May 30, 2017 | — |
| S-1/A | Amended registration statement | Apr 18, 2017 | — |
| S-1 | Registration statement | Feb 7, 2017 | — |
| S-8 | Employee stock plan registration | Dec 17, 2015 | — |
| 424B3 | Prospectus | Nov 6, 2002 | — |
| 424B3 | Prospectus | Nov 6, 2002 | — |
| S-1/A | Amended registration statement | Oct 30, 2002 | — |
| S-1/A | Amended registration statement | Sep 5, 2002 | — |
| S-1/A | Amended registration statement | Jul 30, 2002 | — |
| S-1 | Registration statement | May 29, 2002 | — |
| POS AM | Amendment no. 2 to form s-3 on form s-1 | Jul 30, 2001 | — |
Showing 91 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ENVB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 890821
- Former names
- AMERI Holdings, Inc. (until Dec 30, 2020); SPATIALIZER AUDIO LABORATORIES INC (until May 27, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.